G. Hasko et al., Adenosine inhibits IL-12 and TNF-alpha production via adenosine A(2a) receptor-dependent and independent mechanisms, FASEB J, 14(13), 2000, pp. 2065-2074
Interleukin 12 (IL-12) is a crucial cytokine in the regulation of T helper
1 vs. T helper 2 immune responses. In the present study, we investigated th
e effect of the endogenous purine nucleoside adenosine on the production of
IL-12, In mouse macrophages, adenosine suppressed 12,12 production. Althou
gh the order of potency of adenosine receptor agonists suggested the involv
ement of A(2a) receptors, data obtained with A(2a) receptor-deficient mice
showed that the adenosine suppression of IL-12 and even TNF-alpha productio
n is only partly mediated by A(2a) receptor ligation. Studies with adenosin
e receptor antagonists or the adenosine uptake blocker dipyridamole showed
that adenosine released endogenously also decreases IL-12. Although adenosi
ne increases IL-10 production, the inhibition of IL-12 production is indepe
ndent of the increased IL-10. The mechanism of action of adenosine was not
associated with alterations of the activation of the p38 and p42/p44 mitoge
n-activated protein kinases or the phosphorylation of the c-Jun terminal ki
nase. Adenosine failed to affect steady-state levels of either IL-12 p35 or
p40 mRNA, but augmented IL-10 mRNA levels. In summary, adenosine inhibits
IL-12 production via various adenosine receptors. These results support the
notion that adenosine-based therapies might be useful in certain autoimmun
e and/or inflammatory diseases.